NCT02065219View on ClinicalTrials.gov

Trigger-point Blockade in Persistent Pain After Open Groin Hernia Repair

PHASE3CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

November 30, 2013

Primary Completion Date

April 30, 2014

Study Completion Date

May 31, 2015

Conditions
Inguinal HerniaChronic Pain
Interventions
DRUG

Bupivacaine

10 ml of bupivacaine 2.5 mg/ml deposited by ultra-sound guidance around the spermatic cord

DRUG

Placebo

10 ml 0.9% physiological saline deposited by ultra-sound guidance around the spermatic cord

Trial Locations (1)

2100

Multidisciplinary Pain Center, Neuroscience Center, Copenhagen University Hospital, DENMARK, Copenhagen

All Listed Sponsors
collaborator

Rigshospitalet, Denmark

OTHER

lead

University of Copenhagen

OTHER

NCT02065219 - Trigger-point Blockade in Persistent Pain After Open Groin Hernia Repair | Biotech Hunter | Biotech Hunter